Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Clinical trial NCT00026143 · COMPLETED

Trial details

NCT number: NCT00026143
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Melanoma

Start date: 2001-10-01
Primary completion: 2004-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.